TransMedics Group, Inc. TMDX

Set alert

Price alert · TMDX

All alert types
67.07 USD +0.40 +0.60%

As of Nov 3, 2:58 PM ET

Bid
67.05 × 1
Ask
67.10 × 13
66.36 Day range 68.82
60.11 52-week range 156.00
YTD
-44.87%
1 year
-46.22%
Open
66.90
Prev close
66.67
Mkt cap
2.32B
Vol
328.93K
Avg vol
824.55K
EPS
3.86
P/E
17.38
Div yield
0.00%
More statistics
Low
66.36
High
68.82
Forward P/E
29.58
Beta
2.10
Short ratio
11.14
Inst. own
104.51%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
81.65
200-d avg
94.48
1y target
98.73

5D chart

Chart tools
Interval

Signals (97)
NameTimeAgo
SMA: BullishNov 3, 11:45 AM3 hours ago
MACD: Sell SignalNov 3, 11:25 AM3 hours ago
SMA: BearishNov 3, 11:15 AM3 hours ago
SMA: BullishNov 3, 11:10 AM3 hours ago
SMA: BearishNov 3, 11:05 AM3 hours ago
RSI: OverboughtNov 3, 10:40 AM4 hours ago
SMA: BullishNov 3, 10:05 AM4 hours ago
SMA: BullishNov 3, 10:05 AM4 hours ago
SMA: BearishNov 3, 10:00 AM4 hours ago
SMA: BearishNov 3, 9:55 AM5 hours ago
SMA: BullishNov 3, 9:50 AM5 hours ago
SMA: BullishNov 3, 9:50 AM5 hours ago
SMA: BearishNov 3, 9:40 AM5 hours ago
SMA: BearishNov 3, 9:40 AM5 hours ago
SMA: BullishNov 3, 9:30 AM5 hours ago
SMA: BullishNov 3, 9:30 AM5 hours ago
SMA: BearishNov 2, 3:55 PM23 hours ago
SMA: BearishNov 2, 3:55 PM23 hours ago
SMA: BullishNov 2, 3:20 PM23 hours ago
MACD: Buy SignalNov 2, 3:20 PM23 hours ago

Newest 20 of 97.

Analyst view

Consensus: buy

Buy
Price target (mean) 98.73 +47.2% upside
Target (low)
65.00
Target (mean)
98.73
Target (high)
125.00
Ratings (0m) 13 9 buy · 4 hold · 0 sell
  • Strong buy3
  • Buy6
  • Hold4
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 13
  • 1 month ago 12
  • 2 months ago 12

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

TMDX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.29340.14738 – 0.401670.66-55.5%178.05M+23.8%10
Next quarter0.499270.30964 – 0.570.527-5.3%201.27M+25.2%9
Current year1.511.17 – 1.632.63-42.4%742.18M+22.6%10
Next year2.251.61 – 3.041.51+49.0%874.68M+17.8%10

Upgrades and downgrades

The latest rating changes

TMDX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 13, 2026Canaccord GenuityMaintainedBuyBuy
Oct 7, 2026BarclaysInitiated—Overweight
Sep 8, 2026TD CowenReiteratedBuyBuy
Aug 5, 2026UBSMaintainedNeutralNeutral
Aug 5, 2026Piper SandlerReiteratedOverweightOverweight
Aug 3, 2026NeedhamMaintainedBuyBuy
Jul 28, 2026UBSInitiated—Neutral
Jul 6, 2026Evercore ISI GroupMaintainedOutperformOutperform
Jul 1, 2026TD CowenReiteratedBuyBuy
Jun 30, 2026Canaccord GenuityMaintainedBuyBuy
Jun 18, 2026StifelMaintainedHoldHold
May 26, 2026StifelMaintainedHoldHold
May 6, 2026Canaccord GenuityMaintainedBuyBuy
May 6, 2026TD CowenMaintainedBuyBuy
May 6, 2026StifelMaintainedHoldHold
May 6, 2026Piper SandlerMaintainedOverweightOverweight
May 6, 2026NeedhamMaintainedBuyBuy
Apr 6, 2026Evercore ISI GroupMaintainedOutperformOutperform
Mar 9, 2026StifelMaintainedHoldHold
Feb 25, 2026JP MorganMaintainedNeutralNeutral
Feb 25, 2026OppenheimerMaintainedOutperformOutperform
Feb 25, 2026Piper SandlerMaintainedOverweightOverweight
Feb 25, 2026Evercore ISI GroupMaintainedOutperformOutperform
Feb 25, 2026NeedhamMaintainedBuyBuy
Dec 17, 2025Canaccord GenuityMaintainedBuyBuy
Dec 8, 2025NeedhamMaintainedBuyBuy
Dec 2, 2025Morgan StanleyMaintainedEqual-WeightEqual-Weight
Oct 30, 2025Canaccord GenuityMaintainedBuyBuy
Oct 30, 2025Piper SandlerMaintainedOverweightOverweight
Oct 23, 2025NeedhamUpgradeHoldBuy